Scientific Information

Welcome & Introduction

Chairs: Andrea Lenzi (Italy), Annamaria Moretti (Italy), Walter Malorni (Italy)

Plenary Lecture Gender disparity and public health

Walter Ricciardi (Italy)

I SESSION - GENDER MEDICINE MEETS ONCOLOGY

Chairs: Rossana Berardi (Italy), Paolo Marchetti (Italy), Teresita Mazzei (Italy)

Gender medicine and oncology: current status and challenges

Anna Dorotea Wagner (Switzerland)

Antitumor therapies: gender differences

Fabio Conforti (Italy)

Impact of gender on the toxicity of drug treatments in oncology

Enrico Mini (Italy)

Gender-specific differences in dealing with cancer

Anahita Paula Rassoulian (Austria)

Discussion

Coffee break

II SESSION GENDER IMPACT ON DIFFERENT TUMOUR HYSTOTYPES

Chairs Aldo Morrone (Italy), Novella Luciani (Italy), Federico Cappuzzo (Italy)

Sex and gender in non melanoma skin cancer in Africa Frehiwot

Daba Gutema (Ethiopia)

Sex and gender in head and neck cancer

Susanna Chiocca (Italy)

Gender and sex attention in melanoma

De Simone Paola (Italy)

Impact of gender on the efficacy and toxicity of drug treatment in lung cancer

Pasello Giulia (Italy)

Safety, efficacy, and tolerability of systemic therapies in male breast cancer: are there sex-specific differences?

Patrizia Vici (Italy)

Discussion

Light lunch

Posters Area
Posters view and discussion

Chairs: Cecilia Politi (Italy), Giovannella Baggio (Italy), Alessandra Carè (Italy)

III SESSION GENDER MEDICINE IN ONCOLOGICAL ENDOCRINOLOGY AND CARDIOVASCULAR DISEASES

Chairs Rossella Elisei (Italy), Paolo Falaschi (Italy), Flavia Franconi (Italy)

Sex and gender in the treatment of thyroid cancer and neuroendocrine tumors

Giulia Puliani (Italy)

Oncological osteoporosis: are there differences in sex and gender?

Daniele Santini (Italy)

Gender pharmacology: what do we need to know?

Giuseppe Toffoli (Italy)

Sex and Gender Differences in Diagnosis, Prevention, and Treatment of Cardiotoxicity in Oncology

Alvin Chandra (USA)

Cancer associated venous thromboembolism and sex/gender differences: where do we stand?

Elvira Grandone (Italy)

Discussion

IV SESSION SEX AND GENDER IN PRECLINICAL AND CLINICAL RESEARCH

Chairs Vittorio Unfer (Italy), Giuseppe Novelli (Italy), Elena Ortona (Italy)

Sex chromosomes and oncological diseases

Karen Reue (USA)

Considering sex as a biological variable in basic and clinical studies

Aditi Bhargava (USA)

Insights into the role of estrogen receptors in the pathophysiology of solid tumors

Paola Matarrese/Elena Ortona (Italy)

Dual role of Androgen signaling in skin cancer

Giampaolo Dotto (Switzerland)

Discussion

Parallel session Neuropsycho-oncology and patients advocacy groups

Chairs Andrea Pace (Italy), Annamaria Biancifiori (Italy)

Sex and Gender neuro-oncology: what’s new?

Annamaria Cattaneo (Italy)

Sex and Gender Psycho-Oncology: the therapeutic encounter centered on the uniqueness of people and their own needs

Caruso Rosangela (Italy)

Roundtable for Patient Associations

• Le Perle di Lumia (Giannitto Caterina)
• CAPE (Biancifiori Annamaria)
• IRENE (Fausti Patrizio)
• RUKIJE (Borioni Anna)
• NET Italy Onlus
• Rete Oncologia Pazienti Italia - ROPI (Gori Stefania)
• Altro? ISG?

Discussion

Parallel session NEW FRONTIERS IN GENDER MEDICINE

Chairs Patrizia Palazzi (Italy), Laura Berti (Italy), Lorella Salce (Italy)

Use of gender language in oncology

Beatrice Curci (Italy)

Sex and gender telemedicine in oncology: are there differences?

Digital gender gap in Artificial Intelligence

Darya Majidi (Italy)

Discussion

Andrea Isidori (Italy), Giulia Piaggio (Italy)

Oral Communications

(7-8 minuti più 2-3 minuti di discussione per comunicazione)

Conclusion and ECM surveys

Marialuisa Appetecchia (Italy)